BIS-001-ER

· Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIS-001-ER, covering 2022-08-30 to 2022-08-30. Get the full timeline:

Most recent: Clinical Trial Update: BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures [Phase 1, Phase 2]